Current Drug Discovery Technologies
SJR0.353
AE
AEJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.353 | Q3 | 49.1% | |
| 2024 | — | — | 0.394 | Q3 | 54.5% | |
| 2023 | — | — | 0.319 | Q3 | 50.7% | |
| 2022 | — | — | 0.329 | Q3 | 53.5% | |
| 2021 | — | — | 0.301 | Q4 | 51.4% | |
| 2020 | — | — | 0.319 | Q3 | 52.4% | |
| 2019 | — | — | 0.297 | Q3 | 52.0% | |
| 2018 | — | — | 0.397 | Q3 | 58.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
1875-6220
ISSN
1570-1638
country
AEcoverage
2004-2026